Evommune, Inc. (EVMN)
17.30
+0.18
(+1.05%)
USD |
NYSE |
Jan 02, 10:37
Evommune Shareholders Equity (Quarterly): -183.14M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BillionToOne, Inc. | 179.90M |
| PTC Therapeutics, Inc. | -155.76M |
| Spyre Therapeutics, Inc. | 455.10M |
| Denali Therapeutics, Inc. | 926.20M |
| Quince Therapeutics, Inc. | 1.059M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 84.54M |
| Total Liabilities (Quarterly) | 267.68M |
| Debt to Equity Ratio | -1.408 |
| Current Ratio | 7.761 |